View in EDS HTML Full Text PDF Full Text

Correction: Updated safety results from phase 3 lecanemab study in early Alzheimer's disease.

Saved in:
Bibliographic Details
Title: Correction: Updated safety results from phase 3 lecanemab study in early Alzheimer's disease.
Authors: Honig, Lawrence S.1 (AUTHOR) lh456@cumc.columbia.edu, Sabbagh, Marwan N.2 (AUTHOR), van Dyck, Christopher H.3 (AUTHOR), Sperling, Reisa A.4 (AUTHOR), Hersch, Steven5 (AUTHOR), Matta, Andre5 (AUTHOR), Giorgi, Luigi6 (AUTHOR), Gee, Michelle6 (AUTHOR), Kanekiyo, Michio5 (AUTHOR), Li, David5 (AUTHOR), Purcell, Derk7 (AUTHOR), Dhadda, Shobha5 (AUTHOR), Irizarry, Michael5 (AUTHOR), Kramer, Lynn5 (AUTHOR)
Source: Alzheimer's Research & Therapy. 7/10/2024, Vol. 16 Issue 1, p1-4. 4p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17589193
DOI:10.1186/s13195-024-01507-7